ストックスクリーナーアプリを入手
3.125
8.16%
0.245
前日終値:
$2.88
開ける：
$2.9
24時間の取引高:
6.23M
Relative Volume:
1.85
時価総額：
$398.11M
収益：
$4.21M
当期純損益:
$-97.67M
株価収益率:
-3.3602
EPS:
-0.93
ネットキャッシュフロー:
$-70.76M
1週間 パフォーマンス:
+16.67%
1か月 パフォーマンス:
+13.27%
6か月 パフォーマンス:
+7.41%
1年 パフォーマンス:
-24.21%
1日の値動き範囲:
$2.895
$3.23
1週間の範囲:
$2.5509
$3.23
52週間の値動き範囲:
$2.01
$6.33
Absci Corp Stock (ABSI) Company Profile
ABSI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
3.121 | 348.24M | 4.21M | -97.67M | -70.76M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.90 | 123.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
543.72 | 60.43B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
319.56 | 42.07B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
568.62 | 34.47B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.85 | 27.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-03 | 再開されました | Morgan Stanley | Overweight |
| 2025-01-22 | 開始されました | Needham | Buy |
| 2024-10-02 | 開始されました | Guggenheim | Buy |
| 2024-07-03 | 開始されました | Morgan Stanley | Overweight |
| 2024-03-14 | 開始されました | Scotiabank | Sector Outperform |
| 2023-12-05 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2023-05-04 | 開始されました | H.C. Wainwright | Buy |
| 2022-08-12 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2022-07-18 | 開始されました | Truist | Buy |
| 2022-03-02 | 再開されました | Cowen | Market Perform |
| 2022-02-01 | 開始されました | Berenberg | Buy |
| 2021-11-10 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-08-16 | 開始されました | BofA Securities | Neutral |
| 2021-08-16 | 開始されました | Cowen | Market Perform |
| 2021-08-16 | 開始されました | Credit Suisse | Outperform |
| 2021-08-16 | 開始されました | Stifel | Hold |
すべてを表示
Absci Corp (ABSI) 最新ニュース
Is Absci Corporation stock a growth or value playRapid Gain Targets - Newser
A Quick Look at Today's Ratings for Absci Corp(ABSI.US), With a Forecast Between $7 to $13 - 富途牛牛
ABSI: Riding the Market Waves of Growth and Decline in 2025 - investchronicle.com
How Absci Corporation stock performs during market volatilityHigh Reward Swing Trades - Newser
Why Absci Corporation stock attracts strong analyst attentionEarly Buy Suggestion - Newser
Absci Corporation (NASDAQ:ABSI) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Morgan Stanley Assumes Coverage on Absci Corporation (ABSI) with $7 Target - MSN
Thinking Of Buying Absci Corp (NASDAQ: ABSI) Stock? Here Is What You Should Know - Stocksregister
Absci appoints Mary Szela to board of directors and grants stock options - Investing.com
Former Abbott executive Mary Szela joins Absci’s board of directors By Investing.com - Investing.com South Africa
Sumitomo Mitsui Trust Group Inc. Raises Stock Holdings in Absci Corporation (NASDAQ:ABSI) - MarketBeat
Absci appoints Mary Szela to board of directors - TipRanks
Absci Appoints Biopharma Leader Mary Szela to Board of Directors - GlobeNewswire
Former Abbott executive Mary Szela joins Absci’s board of directors - Investing.com Australia
Absci stock rating initiated at Overweight by Morgan Stanley - Investing.com Canada
Absci assumed with an Overweight at Morgan Stanley - TipRanks
Absci Corp (ABSI) Stock: A Year of Highs and Lows in the Market - investchronicle.com
Absci (NASDAQ:ABSI) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
Top 5 AI & Digital Biotech Companies (July 2025) - Securities.io
Absci (NASDAQ:ABSI) Stock Rating Lowered by Wall Street Zen - Defense World
Institute for Wealth Management LLC. Trims Holdings in Absci Corporation (NASDAQ:ABSI) - MarketBeat
Absci (NASDAQ:ABSI) Stock Rating Upgraded by Wall Street Zen - Defense World
Absci Corporation (NASDAQ:ABSI) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Millennium Management LLC Sells 1,149,603 Shares of Absci Co. (NASDAQ:ABSI) - MarketBeat
Transcript : Absci Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08 - marketscreener.com
Two Sigma Investments LP Raises Stock Position in Absci Co. (NASDAQ:ABSI) - MarketBeat
Deutsche Bank AG Purchases 28,073 Shares of Absci Co. (NASDAQ:ABSI) - Defense World
Absci (NASDAQ:ABSI) Rating Lowered to Sell at Wall Street Zen - MarketBeat
AbSci Corp (ABSI) Sees Borrow Rate Increase | ABSI Stock News - GuruFocus
Woodline Partners LP Decreases Position in Absci Co. (NASDAQ:ABSI) - MarketBeat
Northern Trust Corp Has $1.72 Million Stock Holdings in Absci Co. (NASDAQ:ABSI) - Defense World
Brokerages Set Absci Co. (NASDAQ:ABSI) Price Target at $8.40 - MarketBeat
Wall Street Zen Upgrades Absci (NASDAQ:ABSI) to Hold - Defense World
Ameriprise Financial Inc. Sells 23,668 Shares of Absci Co. (NASDAQ:ABSI) - Defense World
AbSci Corp (ABSI): Key Indicator Shows Noticeable Increase | ABSI Stock News - GuruFocus
Catherine Wood's Strategic Acquisition of Absci Corp Shares - GuruFocus
Schonfeld Strategic Advisors LLC Has $144,000 Stake in Absci Co. (NASDAQ:ABSI) - MarketBeat
Absci to Participate in Upcoming Investor Conferences - GlobeNewswire
Absci Sets Stage for Major AI Breakthroughs at Goldman Sachs and Jefferies Healthcare Conferences - Stock Titan
Needham & Company LLC Reiterates Buy Rating for Absci (NASDAQ:ABSI) - MarketBeat
Price T Rowe Associates Inc. MD Increases Holdings in Absci Co. (NASDAQ:ABSI) - Defense World
Absci Co. (NASDAQ:ABSI) Shares Sold by Stifel Financial Corp - Defense World
Needham & Company LLC Reaffirms “Buy” Rating for Absci (NASDAQ:ABSI) - Defense World
Absci Corp’s Earnings Call: A Promising Outlook - TipRanks
Absci Corporation (NASDAQ:ABSI) Q1 2025 Earnings Call Transcript - Insider Monkey
Absci First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Dimensional Fund Advisors LP Acquires 241,779 Shares of Absci Co. (NASDAQ:ABSI) - Defense World
ABSI: Needham Reiterates Buy Rating and $9 Price Target | ABSI Stock News - GuruFocus
Absci (ABSI) Initiates Phase 1 Study of AI-Designed Antibody ABS-101 | ABSI Stock News - GuruFocus
Absci (ABSI) Launches First Human Trial for ABS-101 - GuruFocus
ABSI: Needham Reiterates Buy Rating and $9 Price Target | ABSI S - GuruFocus
Absci Corp (ABSI) 財務データ
収益
当期純利益
現金流量
EPS
0.86%
0.10%
大文字化:
|
ボリューム (24 時間):